LncRNA XIST protects podocyte from high glucose-induced cell injury in diabetic nephropathy by sponging miR-30 and regulating AVEN expression

References

• Chakrabarti, M., Klionsky, D.J., and Ray, S.K., 2016. miR-30e blocks autophagy and acts synergistically with proanthocyanidin for inhibition of AVEN and BIRC6 to increase apoptosis in glioblastoma stem cells and glioblastoma SNB19 cells. PLoS one, 11 (7), e0158537.
   PubMed Web of Science ®Google Scholar
• Chau, B.N., et al., 2000. Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1. Molecular cell, 6 (1), 31–40.
   PubMed Web of Science ®Google Scholar
• Chen, S., et al., 2020. lncRNA xist regulates osteoblast differentiation by sponging miR-19a-3p in aging-induced osteoporosis. Aging and disease, 11 (5), 1058–1068.
   PubMed Web of Science ®Google Scholar
• Chen, W., et al., 2017. Atgl deficiency induces podocyte apoptosis and leads to glomerular filtration barrier damage. The FEBS journal, 284 (7), 1070–1081.
   PubMed Web of Science ®Google Scholar
• Djebali, S., et al., 2012. Landscape of transcription in human cells. Nature, 489 (7414), 101–108.
   PubMed Web of Science ®Google Scholar
• Eid, A., et al., 2009. Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. Diabetes, 58 (5), 1201–1211.
   PubMed Web of Science ®Google Scholar
• Gu, J., et al., 2016. Olmesartan prevents microalbuminuria in db/db diabetic mice through inhibition of angiotensin II/p38/SIRT1-induced podocyte apoptosis. Kidney & blood pressure research, 41 (6), 848–864.
   PubMed Web of Science ®Google Scholar
• Han, X., et al., 2020. Long non-coding RNA X-inactive-specific transcript contributes to cisplatin resistance in gastric cancer by sponging miR-let-7b. Anti-cancer drugs, 31 (10), 1018–1025.
   PubMed Web of Science ®Google Scholar
• Han, Y., et al., 2018. Reactive oxygen species promote tubular injury in diabetic nephropathy: the role of the mitochondrial ros-txnip-nlrp3 biological axis. Redox biology, 16, 32–46.
   PubMed Web of Science ®Google Scholar
• Huang, S.S., et al., 2017. Resveratrol protects podocytes against apoptosis via stimulation of autophagy in a mouse model of diabetic nephropathy. Scientific reports, 7, 45692.
   PubMed Web of Science ®Google Scholar
• Huang, Y.S., et al., 2014. Urinary Xist is a potential biomarker for membranous nephropathy. Biochemical and biophysical research communications, 452 (3), 415–421.
   PubMed Web of Science ®Google Scholar
• Jin, L.W., et al., 2019. Down-regulation of the long non-coding RNA XIST ameliorates podocyte apoptosis in membranous nephropathy via the miR-217-TLR4 pathway. Experimental physiology, 104 (2), 220–230.
   PubMed Web of Science ®Google Scholar
• Kumar, A. and Mittal, R., 2018. Mapping Txnip: Key connexions in progression of diabetic nephropathy. Pharmacological reports, 70 (3), 614–622.
   PubMed Web of Science ®Google Scholar
• Lee, J.T., 2012. Epigenetic regulation by long noncoding RNAs. Science, 338 (6113), 1435–1439.
   PubMed Web of Science ®Google Scholar
• Lewis, E.J., et al., 1993. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. New England journal of medicine, 329 (20), 1456–1462.
   PubMed Web of Science ®Google Scholar
• Li, A., et al., 2018. LincRNA 1700020I14Rik alleviates cell proliferation and fibrosis in diabetic nephropathy via miR-34a-5p/Sirt1/HIF-1α signaling. Cell death & disease, 9 (5), 461.
   PubMedGoogle Scholar
• Li, S.Y. and Susztak, K., 2016. The long noncoding RNA Tug1 connects metabolic changes with kidney disease in podocytes. The journal of clinical investigation, 126 (11), 4072–4075.
   PubMed Web of Science ®Google Scholar
• Liang, D., et al., 2020. Down-regulation of xist and Mir-7a-5p improves LPS-induced myocardial injury. International journal of medical sciences, 17 (16), 2570–2577.
   PubMed Web of Science ®Google Scholar
• Long, J., et al., 2016. Long noncoding RNA Tug1 regulates mitochondrial bioenergetics in diabetic nephropathy. The journal of clinical investigation, 126 (11), 4205–4218.
   PubMed Web of Science ®Google Scholar
• Marshall, S.M., 2012. Diabetic nephropathy in type 1 diabetes: has the outlook improved since the 1980s? Diabetologia, 55 (9), 2301–2306.
   PubMed Web of Science ®Google Scholar
• Moreno, J.A., et al., 2018. Targeting inflammation in diabetic nephropathy: a tale of hope. Expert opinion on investigational drugs, 27 (11), 917–930.
   PubMed Web of Science ®Google Scholar
• Parving, H.H., et al., 2001. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. New England journal of medicine, 345 (12), 870–878.
   PubMed Web of Science ®Google Scholar
• Reidy, K., et al., 2014. Molecular mechanisms of diabetic kidney disease. The journal of clinical investigation, 124 (6), 2333–2340.
   PubMed Web of Science ®Google Scholar
• Rinn, J.L. and Chang, H.Y., 2012. Genome regulation by long noncoding RNAs. Annual review of biochemistry, 81, 145–166.
   PubMed Web of Science ®Google Scholar
• Rosolowsky, E.T., et al., 2011. Risk for ESRD in type 1 diabetes remains high despite renoprotection. Journal of the American society of nephrology, 22 (3), 545–553.
   PubMed Web of Science ®Google Scholar
• Susztak, K., et al., 2004. Molecular profiling of diabetic mouse kidney reveals novel genes linked to glomerular disease. Diabetes, 53 (3), 784–794.
   PubMed Web of Science ®Google Scholar
• Susztak, K., et al., 2006. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes, 55 (1), 225–233.
   PubMed Web of Science ®Google Scholar
• Tung, C.W., et al., 2018. Glomerular mesangial cell and podocyte injuries in diabetic nephropathy. Nephrology, 23(4), 32–37.
   PubMed Web of Science ®Google Scholar
• Umanath, K. and Lewis, J.B., 2018. Update on diabetic nephropathy: core curriculum 2018. American journal of kidney diseases, 71 (6), 884–895.
   PubMed Web of Science ®Google Scholar
• Wang, L., et al., 2019. MicroRNAs in the progress of diabetic nephropathy: a systematic review and meta-analysis. Evidence-based complementary and alternative medicine 2019, 3513179.
   PubMed Web of Science ®Google Scholar
• Zhang, L. and Jia, X., 2019. Down-regulation of miR-30b-5p protects cardiomyocytes against hypoxia-induced injury by targeting Aven. Cellular & molecular biology letters, 24, 61.
   PubMed Web of Science ®Google Scholar
• Zheng, W., et al., 2020. The lncRNA XIST promotes proliferation, migration and invasion of gastric cancer cells by targeting miR-337. Arab journal of gastroenterology, 21 (3), 199–206.
   PubMed Web of Science ®Google Scholar